Last reviewed · How we verify
NCT04700306: SOPHCIG
Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal
NA trial testing Sophrology in Craving in 17 participants. Terminated before completion.
9 September 2024
Quick facts
| Lead sponsor | Centre Hospitalier Intercommunal Creteil |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 17 |
| Start date | 23 June 2021 |
| Primary completion | 9 September 2024 |
| Estimated completion | 9 September 2024 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Sophrology
Conditions studied
- Craving — all drugs for Craving →
- Cigarette Smoking — all drugs for Cigarette Smoking →
Sponsor
Centre Hospitalier Intercommunal Creteil
Who can join
Adults 18 to 75, any sex, with Craving or Cigarette Smoking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the added value of Sophrology on the intensity of craving during cigarette withdrawal.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04700306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sophrology
Trials testing the same drug.
- NCT05189366 — Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy · NA · terminated
- NCT03167528 — Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients · NA · completed
Other recruiting trials for Craving
Currently open trials in the same condition.
- NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
- NCT06582888 — Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder · EARLY_PHASE1 · recruiting
- NCT06247306 — Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption · NA · recruiting
- NCT06105853 — Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder · NA · recruiting
- NCT05666726 — State-dependent Interoception, Value-based Decision-making, and Introspection · NA · recruiting
Other Centre Hospitalier Intercommunal Creteil trials
Trials by the same sponsor.
- NCT07493785 — Dexmedetomidine for Invasive Ventilation In the NEOnate · Phase 2, PHASE3 · not yet recruiting
- NCT07513051 — DIaphragmatic Swing According to Cpap Flow Output in NEOnates (DISCONEO) · NA · not yet recruiting
- NCT07455942 — Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer · not yet recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
- NCT06339450 — Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04700306 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Intercommunal Creteil
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04700306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing